Spot Trading’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.18M Buy
67,800
+12,000
+22% +$163K 0.02% 1048
2017
Q2
$715K Buy
+55,800
New +$745K 0.01% 1329
2017
Q1
Sell
-13,400
Closed -$132K 3083
2016
Q4
$132K Buy
+13,400
New +$147K ﹤0.01% 2100
2016
Q1
Sell
-64,600
Closed -$1.12M 3635
2015
Q4
$1.12M Sell
64,600
-600
-0.9% -$9.56K 0.01% 1362
2015
Q3
$876K Buy
65,200
+39,200
+151% +$787K 0.01% 1667
2015
Q2
$587K Hold
26,000
0.01% 2009
2015
Q1
$371K Buy
26,000
+6,000
+30% +$86.5K ﹤0.01% 2345
2014
Q4
$193K Sell
20,000
-24,200
-55% -$215K ﹤0.01% 2946
2014
Q3
$402K Sell
44,200
-25,800
-37% -$246K ﹤0.01% 2715
2014
Q2
$692K Sell
70,000
-16,700
-19% -$142K ﹤0.01% 2427
2014
Q1
$1.1M Sell
86,700
-29,400
-25% -$436K 0.01% 1962
2013
Q4
$1.74M Buy
+116,100
New +$1.49M 0.01% 1594

Other funds holding HALO

Spot Trading's HALO Position: Q2 2017 in Review

Spot Trading sold out of Halozyme (HALO) in Q2 2017, closing a stake of 21,353 shares — an estimated $285K sold.

Spot Trading first reported a position in HALO in Q2 2014 and held it in 9 quarters. The position peaked at $277K in Q1 2017. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

  • Spot Trading reported no remaining Halozyme position as of Q2 2017 after selling out during the quarter.
  • Spot Trading sold 21,353 Halozyme shares in Q2 2017, an estimated $285K.
  • Spot Trading first reported a position in Halozyme in Q2 2014 and held it in 9 quarters.
  • Spot Trading's Halozyme position peaked at $277K in Q1 2017.
  • 167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on Spot Trading's 13F filing for Q2 2017, filed 27 Jul 2017.